ANVSライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (27 4月 2024 @ 05:00):

Stats
本日の出来高	1.05M
平均出来高	238 524
時価総額	198.31M
EPS	$0 ( 2024-04-01 )
次の収益日	( $-0.870 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.89
ATR14	$0.171 (0.95%)

Insider Trading

Date	Person	Action	Amount	type
2023-11-20	White Mark K.	Buy	1 990	Common Stock
2023-11-20	Mccarthy Reid	Buy	0	Common Stock
2023-11-20	Hoffman Michael B	Buy	163 880	Common Stock
2023-11-20	Maccecchini Maria-luisa	Buy	40 970	Common Stock
2023-11-20	Hagopian Henry Iii	Buy	820	Common Stock

INSIDER POWER
90.02
Last 98 transactions
Buy: 4 567 241 \| Sell: 3 252 094

ボリューム相関

長: 0.29 (neutral)

短: 0.89 (strong)

Signal:(75.936) Same movement expected

Annovis Bio Inc 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Annovis Bio Inc 相関 - 通貨/商品

-0.11
( neutral )

-0.10
( neutral )

0.00
( neutral )

0.13
( neutral )

-0.68
( moderate negative )

-0.08
( neutral )

Annovis Bio Inc 財務諸表

Annual	2023
収益:	$0
総利益:	$0 (0.00 %)
EPS:	$-6.23

FY	2023
収益:	$0
総利益:	$0 (0.00 %)
EPS:	$-6.23

FY	2022
収益:	$0
総利益:	$0 (0.00 %)
EPS:	$-3.08

FY	2021
収益:	$0.00
総利益:	$0.00 (0.00 %)
EPS:	$-1.900

Financial Reports:

No articles found.

Annovis Bio Inc

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders. It is also developing ANVS405 for protecting the traumatic brain injury and stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.